EDDA Technology Demonstrates the IQQA® Platform of Real-time Interactive Fully 3D Quantitative Solutions for Disease-Centralized Patient Management

PRINCETON, N.J., Nov. 21, 2012 /PRNewswire/ -- EDDA Technology announced today that the company will demonstrate the generalization of its proven technologies of Real-time Interactive Fully 3D Quantitative Imaging in an enhanced IQQA Platform at the 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).  

The enhanced IQQA Platform answers to the challenge of maximizing the potential of imaging in coordinating an optimal workflow involving multiple stakeholders along the cycle of patient care, including radiologists, interventional radiologists, surgeons, and oncologists. The decision support provided by IQQA covers the full range of disease-centralized patient management in the abdominal and thoracic areas, from detection, diagnosis, pre-treatment planning, to intra-operative navigation, and post-treatment follow up.

A market-proven product of the platform, IQQA^®-Liver for 3D real-time quantitative planning and assessment, is currently used by radiologists and surgeons worldwide in liver surgery, transplantation, and interventional centers.  Substantial time saving and improved care was demonstrated in over 4,000 cases using IQQA-Liver in hospitals since the first commercial system installation in Q2 2009.  

Real-time interactive applications with fully 3D capabilities are the prerequisite of strong clinical decision support from imaging. The same proprietary technology behind IQQA^®-Liver has now been extended to other organs in thoracic and abdominal application areas; to offer physicians real-time quantitative decision support that goes well beyond the 3D visualization domain. It enables physicians to utilize the quantitative information of the organ, lesion, vessels, and ducts, as well as the quantified spatial relations among these anatomies of interests, to make their own individualized decision based upon own knowledge and experience in a user-friendly real-time interactive way, thus improving efficiency, and patient care.  

IQQA®-Guide (work-in-progress) further brings the Real-time Interactive Fully Quantitative technology into the operating room by offering real-time 3D image guidance for abdominal and thoracic biopsy, interventional procedure and surgery. IQQA-Guide utilizes a 3D map of individualized anatomic representations extracted from multi-modality image datasets. Through sophisticated registration algorithms and state-of-the-art electromagnetic tracking, it provides real-time tracking and referencing to anatomic features of interest in 3D. As a result, physicians are supported to "see in depth" beyond the anatomy surface during a procedure, and to quantitatively locate, assess, and adjust the position of instruments relative to the full patient-specific 3D anatomy of lesion, vessels, organs and segments.

EDDA Technology will also exhibit other IQQA^® Family of Products in Booth #7556 at the RSNA 2012, including IQQA^®-Liver Function and IQQA-BodyImaging (hosted by the IQQA^®-Platform as works-in-progress), IQQA^®-Chest Enterprise CAD (Computer Aided Detection) for assisting physician's detection of small lung nodules from digital chest X-ray, and IQQA^® –TomoS CAD (work-in-progress) for Digital X-ray Tomosynthesis. The first prospective study on chest X-ray CAD published in journal (Academic Radiology Vol. 15:5) demonstrated a significant sensitivity increase of physician's nodule detection from 63.8% without IQQA-Chest to 92.7% with IQQA-Chest assistance (while specificity kept high at 96.2% from the previous 98.1%).  

About EDDA Technology

EDDA Technology, Inc. is an innovative clinical computer solution provider in healthcare imaging and analysis. EDDA offers a series of next generation computer assistance solutions to the entire patient care management cycle, including enabling early detection and diagnosis of diseases, as well as enhancing efficiency and precision in treatment planning, management, and follow-up. EDDA's goal is to deliver, with broad accessibility, advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton, New Jersey, and has subsidiaries in Shanghai and Suzhou, China. IQQA^® is a registered trademark of EDDA Technology. www.eddatech.com

SOURCE EDDA Technology, Inc.